(CYTX)

All Comments on CYTX

  • commenter
    Roy P.
    Oct 06 01:03 PM
    5 Emerging Healthcare Stock Picks for 2008 [view article]
    Mike, I believe Thermogenesis(KOOL) is a much better investment.

    Last year KOOL had 1(cord blood) major revenue source, this year it has 4(cord blood, MXP/Res-Q for bone marrow, adipose and Vantus lab.).

    year/year revenue expected to be 30-35% higher this year, profit margin expected to go from 33% last year to over 40% this year and becomes profitable.
    Reply
  • commenter
    Roy P.
    Oct 06 12:16 PM
    Cytori Raises Cash and Announces Second Quarter Results [view article]
    Thermogenesis(KOOL) is a much better investment.

    Last year KOOL had 1(cord blood) major revenue source, this year it has 4(cord blood, MXP/Res-Q for bone marrow, adipose and Vantus lab.).

    year/year revenue expected to be 30-35% higher, profit margin expected to go from 33% to over 40% and becomes profitable.

    Reply
  • commenter
    p. smith
    Aug 29 11:24 PM
    How to Profit from Stem Cell R&D - Barron's [view article]
    KOOL is the early Cisco System of stem cell research and therapies, its products are with the highest quality and CE and FDA approved.

    KOOL under the leadership of Bill Osgood has been a very different company, they have solved the disposable bag problem, increases supply sources to 3 and most of all, they have got the CE and FDA approval for their killer product - the Marrow Xpress.

    For all you have lost money investing in KOOL, you have got to come back, this time it'll be different.     Reply
  • commenter
    p. smith
    Aug 25 03:53 PM
    Cytori Therapeutics: The Stem Cell 'Celution' for Success [view article]
    The only winner is the Cisco of stem cell research...Thermogenes... Reply
  • commenter
    L. SMITH
    Aug 17 10:58 AM
    Cytori Therapeutics: The Stem Cell 'Celution' for Success [view article]
    LOTS OF HOT AIR... Reply
  • commenter
    the biotech
    onion
    Jul 17 07:49 PM
    Cytori Therapeutics: The Stem Cell 'Celution' for Success [view article]
    bioblog.biologicllp.co... has a good rundown of this company's perverse distortion of their patents Reply
  • commenter
    CPST1
    Jul 08 05:04 PM
    Cytori Therapeutics: The Stem Cell 'Celution' for Success [view article]
    www.artecel.com/docs/A...


    On Jul 07 12:56 PM Regenerative Review wrote:

    > What this author/shareholder glaringly fails to mention is that Cytori
    > just lost their license to the global rights to the human adipose
    > stem cells when UCLA lost their patent dispute with the University
    > of Pittsburg. So, while they may have a machine to process the adipose,
    > they have no rights to do so. The company deceptively plays down
    > the significance of this ominous event in their press release. In
    > my opinion, Cytori is a massive short sale candidate as the stock
    > is poised to take a free fall!     Reply
  • commenter
    Regenerative
    Review
    Jul 07 12:56 PM
    Cytori Therapeutics: The Stem Cell 'Celution' for Success [view article]
    What this author/shareholder glaringly fails to mention is that Cytori just lost their license to the global rights to the human adipose stem cells when UCLA lost their patent dispute with the University of Pittsburg. So, while they may have a machine to process the adipose, they have no rights to do so. The company deceptively plays down the significance of this ominous event in their press release. In my opinion, Cytori is a massive short sale candidate as the stock is poised to take a free fall! Reply
  • commenter
    fireball
    Jul 06 12:37 PM
    Cytori Therapeutics: The Stem Cell 'Celution' for Success [view article]
    good reasonable article. will look further into cytx. Reply
  • commenter
    montyman
    Jun 03 01:59 AM
    10 Biotechs in Stem Cells that Could Profit Under the Democrats [view article]
    I just read a story about how stem cell therapy (autologous from liposuction) is now approved for dogs with knee osteoarthritis. It is reported to greatly ease the symptoms. Also, such treatment has been available for horses since 2003. But nothing even close for people? WHAT THE HELL??????? Reply
  • commenter
    User 95455
    Jun 02 10:49 AM
    10 Biotechs in Stem Cells that Could Profit Under the Democrats [view article]
    what about Opexa? Reply
  • commenter
    kharrin49
    Jun 02 08:35 AM
    10 Biotechs in Stem Cells that Could Profit Under the Democrats [view article]
    I agree jefferey Reply
  • commenter
    kharrin49
    Jun 02 08:35 AM
    10 Biotechs in Stem Cells that Could Profit Under the Democrats [view article]
    Lets go back to when the democrats took over the majority in congress. Lets see what happenned ? Without even going back to check I can tell you with a good amount of certainty that ALL of these companies took a good jump in share price. Now does that mean they are good investments certainly not. However the truth of the matter is that the chances of most stem cell companies seeing their share price rise with the democrats taking over is a fair guess. I belive the heading was companies that would stand to profit from democrats We have had right wing republicans spout lies to the american public for far to long. To listen to a senior senator who happenned to be a doctor lumping all stem cell research together as killing human life was exactly what the american people were getting from our goverment..And yes I believe all these companies if they are still around will benifit from democrats taking control...Out of the mentioned companies I do own Osiris and have in the past one year or more going back owned others mentioned. Reply
  • commenter
    Medici
    Jun 01 09:14 PM
    My Website
    10 Biotechs in Stem Cells that Could Profit Under the Democrats [view article]
    I can answer the debate whether the names above would be viable if a democrat took office:

    They are a "Physcological Trade"

    For a brief minute the masses would believe that these stocks would be the proper play amid the election of a Democratic President.

    The rally would be swift and then falter, the stocks mentioned above would rally on cursory research, but would eventually and most probably fall lower than where they were previous to their rally.

    Then and only then should any of these stocks be judged and strictly on their merits if any-

    Reply
  • commenter
    in4thelongha
    ul
    Jun 01 03:55 PM
    10 Biotechs in Stem Cells that Could Profit Under the Democrats [view article]
    Other criteria one should consider before investing in these companies is cash on hand to burn rate, and patents...most stem cell plays are on very shaky financial footings. GERN is an exception, they are well funded. GERN's sh/pr has recently taken a 20% hit due to the FDA placing a clinical hold on its experimental treatment for spinal injury. The stock has recovered a bit from already, but likely will regain the $5.00 level when the FDA comes to its senses or Bush is booted out of office. Expect McCain to be as, or nearly as favorably disposed towards stem cell research as the Democrats...he isn't exactly beholden to or a champion of the views held by the religious right. GERN has a rather large collection of patents holdings as well...I suspect BP would like to acquire these on the cheap. Jan. calls on GERN are my bet. Reply
Loading...
Symbols:
Authors:
Quick Links: